Canadian universities are making a bold move to keep the economic benefits of their groundbreaking research at home. The University of Toronto and McMaster University have joined forces to launch a new $40-million venture capital fund, the Genesys University Seed Fund, dedicated to supporting life sciences startups, primarily spinouts from their own institutions. This initiative is a significant step towards breaking the trend of Canadian researchers' discoveries benefiting foreign economies. With a 20% contribution from U of T and a $5-million investment from McMaster, the fund is also bolstered by the Ontario government's Venture Ontario, the Temerty Foundation, and Royal Bank of Canada. The fund's focus on medical devices and drugs targeting cancer and heart and brain ailments is particularly promising, given the current lack of domestic investors in Canadian life sciences venture capital. This shift is evident in the success of similar funds, such as the Weston Family's Wittington Innovation Fund and the Canadian Cancer Society-Terry Fox Foundation fund, managed by Lumira Ventures. The Genesys fund, inspired by MIT and UC Berkeley's efforts, aims to signal the importance of homegrown innovations to the economy. It's a response to the humbling reality that while Canada has made groundbreaking discoveries, such as insulin and stem cells, the commercialization has largely occurred abroad. Canadian institutions typically generate minimal licensing revenue from campus inventions compared to their U.S. counterparts. The University of Toronto, in particular, has been working to bridge this gap since the sale of Connaught Labs in 1972. The Genesys fund's success is tied to the strong track record of Genesys Capital, which has achieved significant returns through the successful exits of Inversago Parma and Fusion Pharmaceuticals. This partnership with U of T and McMaster is seen as a strategic move to diversify deal flow and consider opportunities beyond the two schools. The initiative is a testament to the power of collaboration between universities and venture capital firms, aiming to foster a thriving ecosystem of innovation and entrepreneurship in Canada.
